1. Home
  2. CHMI vs HOWL Comparison

CHMI vs HOWL Comparison

Compare CHMI & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.54

Market Cap

98.5M

Sector

Real Estate

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.78

Market Cap

30.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHMI
HOWL
Founded
2012
2017
Country
United States
United States
Employees
14
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.5M
30.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CHMI
HOWL
Price
$2.54
$0.78
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$3.00
$5.00
AVG Volume (30 Days)
190.2K
325.6K
Earning Date
05-05-2026
03-27-2026
Dividend Yield
14.60%
N/A
EPS Growth
N/A
18.40
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$59.20
N/A
P/E Ratio
$139.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.17
$0.53
52 Week High
$3.44
$2.23

Technical Indicators

Market Signals
Indicator
CHMI
HOWL
Relative Strength Index (RSI) 32.90 52.58
Support Level $2.21 $0.56
Resistance Level $2.74 $0.90
Average True Range (ATR) 0.08 0.08
MACD -0.01 -0.00
Stochastic Oscillator 0.00 42.16

Price Performance

Historical Comparison
CHMI
HOWL

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: